Journal
RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY
Volume 7, Issue 2, Pages 102-114Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/18722148113079990006
Keywords
Cancer stem cells; chemotherapy; mitochondria; cell death; apoptosis
Categories
Funding
- Portuguese Foundation for Science and Technology (FCT) [PTDC/QUI-BIQ/101052/2008, PTDC/SAU-TOX/117912/2010]
- FEDER/Compete/National Budget funds
- FCT [BI-PTDC/QUI-BIQ/101052/2008, SFRH/BD/66138/2009]
- Seventh Framework Programme of the European Union [PIEF-GA-2009-251850]
Ask authors/readers for more resources
Complete knowledge about the evolution of the carcinogenic process has to include cancer stem cells (CSCs), which are essential to understand tumor occurrence, recurrence, and also its reduction rate after radio- and/or chemotherapeutic treatments. Understanding CSCs physiology and metabolism may be crucial for the development of novel effective therapies. Therefore, being mitochondria an undeniable target for cancer therapy and a central hub in metabolism and cell and death decisions, it is essential to take this organelle into account and explore its actions and involvements in the context of CSCs physiology. In this review, we focus on recent patents and discoveries about mitochondrial bioenergetics and physiology of CSCs. A full understanding of the role of mitochondrial activity in CSCs and the creation of new strategies, methods and discoveries to support actual treatments with novel ones are of pivotal importance in order to ultimately eradicate cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available